Prenatal Exposure of Bupropion May Enhance Agitation, Anxiety Responses, and Sensitivity to Cocaine Effects in Adult Mice

Shu-Wen Su；Chian-Fang G. Cherng；Yin-Chiu Lin；Lung Yu

prenatal ； stress ； excitability ； sex ； mice ； cocaine ； reward ； sensitization

The Chinese Journal of Physiology

50卷1期（2007 / 02 / 28）

1 - 8

英文

Major depression and dysthymia afflict a proportion of gravid and breast-feeding women. These women are frequently recommended on antidepressants to relieve their symptoms even if the drug effects on fetal growth and postnatal development are not completely known. In a previous study, we reported that prenatal bupropion exposure seemed to enhance the hedonic value of cocaine in adult mice. This study was undertaken to examine the dose-related effects for prenatal bupropion exposure on the stress susceptibility, cocaine-associated reinforcing property, and cocaine-induced behavioral sensitization in adult mice. Our results showed that various doses (ranging 12.5-50 mg/kg) of prenatal bupropion administration at the third trimester of pregnancy did not affect body weight of the adult mice. Bupropion administration at 50 mg/kg enhanced both ambulatory and rearing responses in the open field test. Moreover, bupropion administration (at 25 and 50 mg/kg) significantly decreased the numbers in open arm entry in the elevated plus maze test. Furthermore, prenatal bupropion treatment appeared to facilitate the cocaine-induced place preference in a sex-dependent manner. Finally, prenatal bupropion exposure (at 25 and 50 mg/kg) accelerated and elevated the development of cocaine-induced sensitization in locomotor activity. While the antidepressant and smoking-curbing effects of bupropion have been addressed in literature, we suggest that prenatal bupropion exposure could run a risk of enhancing individual's agitation, stress susceptibility and cocaine stimulating propensity in adulthood.

1. Chen, H.H.,Yang, Y.K.,Yeh, T.L.,Cherng, C.F.,Hsu, H.C.,Hsiao, S.Y.,Yu, L.(2003).Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice.Chinese J. Physiol.,46,169-174.
   連結：
2. Hsiao, S.Y.,Cherng, C.G.,Yang, Y.K.,Yeh, T.L.,Yu, L.(2005).Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice.Chinese J. Physiol.,48,1-7.
   連結：
3. Lien, W.H.,Yeh, T.L.,Yang, Y.K.,Cherng, C.G.,Chen, H.H.,Chen, P.S.,Yu, L.(2004).Cycloheximide enhances maintenance of methamphetamine-induced conditioned place preference.Chinese J. Physiol.,47,23-30.
   連結：
4. Ansorge, M.S.,Zhou, M.,Lira, A.,Hen, R.,Gingrich, J.A.(2004).Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.Science,306,879-881.
5. Ascher, J.A.,Cole, J.O.,Colin, J.N.,Feighner, J.P.,Ferris, R.M.,Fibiger, H.C.,Golden, R.N.,Martin, P.,Potter, W.Z.,Richelson, E.(1995).Bupropion: a review of its mechanism of antidepressant activity.J. Clin. Psychiatry,56,395-401.
6. Borsini, F.,Podhorna, J.,Marazziti, D.(2002).Do animal models of anxiety predict anxiolytic-like effects of antidepressants.Psychopharmacology (Berl),163,121-141.
7. Carrasco, M.C.,Vicens, P.,Vidal, J.,Redolat, R.(2004).Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice.Prog. Neuropsychopharmacol. Biol. Psychiatry,28,1135-1141.
8. Cohen, L.S.,Rosenbaum, J.F.(1998).Psychotropic drug use during pregnancy: weighing the risks.J. Clin. Psychiatry,59,18-28.
9. Cooper, B.R.,Hester, T.J.,Maxwell, R.A.(1980).Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo.J. Pharmacol. Exp. Ther.,215,127-134.
10. Crone, C.C.,Gabriel, G.M.(2004).Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.Clin. Pharmacokinet.,43,361-394.
11. Dong, J.,Blier, P.(2001).Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.Psychopharmacology (Berl),155,52-57.
12. Feighner, J.P.(1999).Mechanism of action of antidepressant medications.J. Clin. Psychiatry,60,4-11.
13. Hendrick, V.,Stowe, Z.N.,Altshuler, L.L.,Hwang, S.,Lee, E.,Haynes, D.(2003).Placental passage of antidepressant medications.Am. J. Psychiatry,160,993-996.
14. Hughes, J.R.,Stead, L.F.,Lancaster, T.(2003).Antidepressants for smoking cessation.Cochrane Database Syst. Rev.,2
15. Jackson, L.R.,Robinson, T.E.,Becker, J.B.(2006).Sex differences and hormonal influences on acquisition of cocaine self-administration in rats.Neuropsychopharmacology,31,129-138.
16. Joshi, D.,Naidu, P.S.,Singh, A.,Kulkarni, S.K.(2005).Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice.Pharmacology,75,93-97.
17. Kalivas, P.W.,Pierce, R.C.,Cornish, J.,Sorg, B.A.(1998).A role for sensitization in craving and relapse in cocaine addiction.J. Psychopharmacol.,12,49-53.
18. Kulin, N.A.,Pastuszak, A.,Sage, S.R.,Schick-Boschetto, B.,Spivey, G.,Feldkamp, M.,Ormond, K.,Matsui, D.,Stein-Schechman, A.K.,Cook, L.,Brochu, J.,Rieder, M.,Koren, G.(1998).Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective control multicenter study.J. Am. Med. Assoc.,279,609-610.
19. Li, S.X.,Perry, K.W.,Wong, D.T.(2002).Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.Neuropharmacology,42,181-190.
20. Marcus, S.M.,Barry, K.L.,Flynn, H.A.,Tandon, R.,Greden, J.F.(2001).Treatment guidelines for depression in pregnancy.Int. J. Gynaecol. Obstet,72,61-70.
21. Pellow, S.,File, S.E.(1986).Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.Pharmacol. Biochem. Behav.,24,525-529.
22. Pohland, R.C.,Byrd, T.K.,Hamilton, M.,Koons, J.R.(1989).Placental transfer and fetal distribution of fluoxetine in the rat.Toxicol. Appl. Pharmacol.,98,198-205.
23. Preskorn, S.H.,Othmer, S.C.(1984).Evaluation of bupropion hydrochloride: the first of a new class of atypical antidepressants.Pharmacotherapy,4,20-34.
24. Redolat, R.,Gomez, M.C.,Vicens, P.,Carrasco, M.C.(2005).Bupropion effects on aggressiveness and anxiety in OF1 male mice.Psychopharmacology (Berl),177,418-427.
25. Richmond, R.,Zwar, N.(2003).Review of bupropion for smoking cessation.Drug Alcohol Rev.,22,203-220.
26. Rygula, R.,Abumaria, N.,Flugge, G.,Fuchs, E.,Ruther, E.,Havemann-Reinecke, U.(2005).Anhedonia and motivational deficits in rats: impact of chronic social stress.Behav. Brain Res.,162,127-134.
27. Salin-Pascual, R.J.,Alcocer-Castillejos, N.V.,Alejo-Galarza, G.(2003).Nicotine dependence and psychiatric disorders.Rev. Invest. Clin.,55,677-693.
28. Sasaki-Adams, D.M.,Kelley, A.E.(2003).Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior.Neuropsychopharmacology,25,440-452.
29. Simon, N.M.,Emmanuel, N.,Ballenger, J.,Worthington, J.J.,Kinrys, G.,Korbly, N.B.,Farach, F.J.,Pollack, M.H.(2003).Bupropion sustained release for panic disorder.Psychopharmacol. Bull.,37,66-72.
30. Solhkhah, R.,Wilens, T.E.,Daly, J.,Prince, J.B.,Van Patten, S.L.,Biederman, J.(2005).Bupropion SR for the treatment of substanceabusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders.J. Child Adolesc. Psychopharmacol.,15,777-786.
31. Stahl, S.M.(1998).Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.J. Clin. Psychiatry,59,23-29.
32. Tomarken, A.J.,Dichter, G.S.,Freid, C.,Addington, S.,Shelton, R.C.(2004).Assessing the effects of bupropion SR on mood dimensions of depression.J. Affect Disord.,78,235-241.
33. Van Gaalen, M.M.,Steckler, T.(2000).Behavioural analysis of four mouse strains in an anxiety test battery.Behav. Brain Res.,115,95-106.
34. Zarrindast, M.R.,Hosseini-Nia, T.(1988).Anorectic and behavioural effects of bupropion.Gen. Pharmacol.,19,201-204.
35. Zimmerman, M.,Posternak, M.A.,Attiullah, N.,Friedman, M.,Boland, R.J.,Baymiller, S.,Berlowitz, S.L.,Rahman, S.,Uy, K.K.,Singer, S.,Chelminski, I.(2005).Why isn`t bupropion the most frequently prescribed antidepressant.J. Clin. Psychiatry,66,603-610.
36. Zocchi, A.,Varnier, G.,Arban, R.,Griffante, C.,Zanetti, L.,Bettelini, L.,Marchi, M.,Gerrard, P.A.,Corsi, M.(2003).Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.Neurosci. Lett.,345,73-76.

1. Yeh, Tzung Lieh,Yang, Yen Kuang,Wang, Yu-Shan,Lu, Ru-Band,Lee, I Hui,Chuang, Hui-Yu,Chu, Chun-Hsien,Cheng, Ling-Yi,Chen, Shiou-Lan,Chen, Shih-Heng,Chen, Po See,Chang, Yun-Hsuan(2014).Venlafaxine, Paroxetineand and Milnacipran for Major Depressive Disorder: A Pragmatic 24-Week Study.中國生理學雜誌,57(5),265-270.